Attend virtual education event for gynecologic cancer care

March 24, 2022 Providence Cancer Institute of Oregon

Join Andrea Hardy, RN, BSN, Providence gynecologic oncology nurse care coordinator, on March 9 for Coping with Chemotherapy. This is a free, virtual educational event for gynecologic cancer patients and their caregivers presented by the Ovarian Cancer Alliance of Oregon & SW Washington in collaboration with Providence Cancer Institute of Oregon.

Andrea will help empower patients to take an active role in their own health care by helping them understand chemotherapy and its side effects, both physically and emotionally.

Topics will include:

  • Taking an active role in your care
  • Understanding chemotherapy
  • Most common types of chemotherapy, including immunotherapy and oral PARP inhibitors
  • Understanding and managing the side effects of chemotherapy
  • Communicating with your health care team

Event details

Wednesday, March 9, 2022

5:00 p.m. - 6:15 p.m. PT

Register here

 

About the presenter

Andrea Hardy, RN, BSN, is a Gynecologic Oncology Nurse Care Coordinator at Providence Cancer Institute of Oregon. She cares for patients with gynecologic cancer throughout their diagnosis, treatment, and survivorship. Among her various nursing services, Andrea provides patient education for symptom management over the course of treatments, starting with chemotherapy. This support helps to ease the journey into the unknown and empowers patients to participate in their own health care.

About the Providence Gynecologic Oncology Program

The Providence Gynecologic Cancer Program provides highly specialized care for patients diagnosed with ovarian, cervical, uterine, vaginal, vulvar and other female reproductive tract cancers, as well as pre-cancerous conditions. Patients receive advanced treatments, from robotic surgery to immunotherapy, with the opportunity to participate in clinical trials. To learn more, visit ProvidenceOregon.org/gyncancer.

Related resources

Gynecologic oncology care now available at Providence Cancer Institute

Clinical trial aims to help premenopausal women at risk for ovarian cancer

Phase II study of neoadjuvant combination therapy for ovarian cancer

Previous Article
Three studies focus on improving treatments for gastrointestinal cancers
Three studies focus on improving treatments for gastrointestinal cancers

People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new...

Next Article
Better Outcomes Thru Bridges (BOB) Programs
Better Outcomes Thru Bridges (BOB) Programs

The Better Outcomes thru Bridges (BOB) Programs focus on serving some of our community’s most vulnerable an...